tRNA binding to antitumor drug doxorubicin and its analogue
about
Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.RNA fragments mimicking tRNA analogs interact with cytochrome c
P2860
tRNA binding to antitumor drug doxorubicin and its analogue
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
tRNA binding to antitumor drug doxorubicin and its analogue
@ast
tRNA binding to antitumor drug doxorubicin and its analogue
@en
tRNA binding to antitumor drug doxorubicin and its analogue
@nl
type
label
tRNA binding to antitumor drug doxorubicin and its analogue
@ast
tRNA binding to antitumor drug doxorubicin and its analogue
@en
tRNA binding to antitumor drug doxorubicin and its analogue
@nl
prefLabel
tRNA binding to antitumor drug doxorubicin and its analogue
@ast
tRNA binding to antitumor drug doxorubicin and its analogue
@en
tRNA binding to antitumor drug doxorubicin and its analogue
@nl
P2093
P2860
P1433
P1476
tRNA binding to antitumor drug doxorubicin and its analogue
@en
P2093
Gervais Bérubé
Heidar-Ali Tajmir-Riahi
Marc Beauregard
P2860
P304
P356
10.1371/JOURNAL.PONE.0069248
P407
P577
2013-07-29T00:00:00Z